Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-23-000091
Filing Date
2023-11-02
Accepted
2023-11-02 16:06:51
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20230930.htm   iXBRL 10-Q 1401643
2 EX-5.1 allo-20230930xex51.htm EX-5.1 16376
3 EX-10.1 allo-20230930xex101.htm EX-10.1 152082
4 EX-10.2 allo-20230930xex102.htm EX-10.2 147015
5 EX-10.3 allo-20230930xex103.htm EX-10.3 835177
6 EX-10.4 allo-20230930xex104.htm EX-10.4 34707
7 EX-31.1 allo-20230930xex311.htm EX-31.1 9788
8 EX-31.2 allo-20230930xex312.htm EX-31.2 9753
9 EX-32.1 allo-20230930xex321.htm EX-32.1 7017
15 allogenefooter.jpg GRAPHIC 3922
16 allogenelogo.jpg GRAPHIC 14655
17 cooleya02a.jpg GRAPHIC 10201
  Complete submission text file 0001737287-23-000091.txt   7976779

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20230930.xsd EX-101.SCH 48275
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20230930_cal.xml EX-101.CAL 51630
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20230930_def.xml EX-101.DEF 256798
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20230930_lab.xml EX-101.LAB 631891
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20230930_pre.xml EX-101.PRE 388960
64 EXTRACTED XBRL INSTANCE DOCUMENT allo-20230930_htm.xml XML 778333
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 231372258
SIC: 2836 Biological Products, (No Diagnostic Substances)